Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Altered levels of cerebrospinal fluid (CSF) peptides related to Alzheimer’s disease (AD) are associated with pathologic AD diagnosis, although cognitively normal subjects can also have abnormal levels of these AD biomarkers. To identify novel CSF biomarkers that distinguish pathologically confirmed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu, William T., Chen-Plotkin, Alice, Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., Pickering, Eve, Kuhn, Max, Chen, Yu, McCluskey, Leo, Elman, Lauren, Karlawish, Jason, Hurtig, Howard I., Siderowf, Andrew, Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880811/
https://ncbi.nlm.nih.gov/pubmed/20232070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-010-0667-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados